InvestorsHub Logo

Yooper61

12/19/18 7:38 AM

#251967 RE: TheDane #251948

To you and Daupers: If FDA P3 approval and a drug that is Plug and Play ready = Blue Sky, they why hasn't BP swooped in on SNGX or Galera both already in P3?


SNGX is on the NASDAQ with a MC of $16.8M, with cash of $11.7M. Galera is privately healed.